ALPHINA THERAPEUTICS
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Its focus is on leveraging the synthetic lethal context of certain cancer patient subsets that have NAD Metabolic Deficiencies (NMD) through the development of companion diagnostics. Their goal is to develop best-in-class targeted therapies against the NAD pathway nodes in patients whose cancers exhibit hallmarks of NMD and rapidly translate these into the clinic.
ALPHINA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Westport, Connecticut, United States
Country:
United States
Total Employee:
1+
Status:
Closed
Contact:
(203) 435-2255
Total Funding:
16.85 M USD
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Investors List
Connecticut Innovations
Connecticut Innovations investment in Venture Round - Alphina Therapeutics
HighCape Partners
HighCape Partners investment in Venture Round - Alphina Therapeutics